Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 14. May 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8912  Previews Next
   
   Articles 1 - 20 / 178233  
   
The role of extracellular vesicles-associated proteins markers in prostate cancer: a review.
Discov Oncol
Said DS, Abdullah MNH, Nurdin A.
PMID: 42133214 [PubMed - as supplied by publisher]


APOE ε2/ε3 is associated with multi-layered protection against prostate cancer in Chinese men.
World J Urol
Wang K, Zhang S, Chen M, Duan X, Xie Y, Yang X, Zhong Y, Yu P, Yang M, Wei Z, Tao Z, Liu W.
PMID: 42133096 [PubMed - indexed for MEDLINE]


Chemotherapy-induced anemia as a prognostic factor for overall survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and cystectomy.
World J Urol
Lafitte E, Sfumato P, Walz J, Billon E, Branger N, Vicier C, Rybikowski S, Guérin M, Maubon T, Beaufils M, Seguin L, Salem N, Brunelle S, Pignot G, Gravis G.
PMID: 42132947 [PubMed - indexed for MEDLINE]


Toward multimodal integration of colorectal cancer and chronic kidney disease: transcriptomic modeling as a framework for the SIRIO study "Spatial radiomics and transcriptomics to the discovery of the cross-link between colon cancer and chronic kidney disease".
Radiol Oncol
Fusco R, Granata V, Belli A, F Perna A, Capasso G, Caraglia M, Pace U, Delrio P, Docimo L, Gambardella C, Lucido FS, Floris M, Locci G, Runfola M, Giannascoli D, Izzo M, Sorgente E, Borriello M, Izzo F, Simeoni M, Petrillo A, SIRIO Trial Collaborators.
PMID: 42132448 [PubMed - as supplied by publisher]


Interobserver variability in dominant intraprostatic lesion delineation using (68)Ga-PSMA PET/CT for localized prostate cancer.
Rep Pract Oncol Radiother
Devran BZ, Cetin IA, Cagliyan F, Özgüven S, Öne.
PMID: 42131465 [PubMed]


Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma.
Int J Surg Case Rep
Shrivastava N, Mitra S, Pande S.
PMID: 42130550 [PubMed]


Plasmon-Enhanced Magnetic Fluorescent Nanoprobe for Ultrasensitive Detection of Urinary miRNA-96 Enabling Early Diagnosis and Risk Stratification of Bladder Cancer.
Anal Chem
Zhang D, Li M, Yang B, Yan Z, Ding C, Huang Y.
PMID: 42130209 [PubMed - as supplied by publisher]


Exploring the Efficacy of Immunotherapy in Combination with Surgical Resection in High-risk Muscle-invasive Bladder Cancer.
Iran J Allergy Asthma Immunol
Li Z, Liu C, Wang H.
PMID: 42130139 [PubMed - indexed for MEDLINE]


Rezvilutamide in combination with androgen deprivation therapy (ADT) with or without docetaxel in the neoadjuvant treatment of oligometastatic prostate cancer (REDOOM): study protocol for an open-label, parallel-cohort, multicentre clinical study.
BMJ Open
Chen ZJ, Zhu XX, Huang H, Ding YZ, Zhuang YD, Wang L, Li P, Yu KY, Chen HD, Wang HL, Li HY, Cai B, Deng ZX, Pan Y, Yang Y, Li P, Huang KT, Ji XW, Lin Q, Chen W.
PMID: 42129992 [PubMed - indexed for MEDLINE]


Bladder cancer segmentation using u-net-based deep-learning.
Sci Rep
Patil B, Hadjiiski L, Sun D, Chan HP, Cohan RH, Caoili EM, Zhou C.
PMID: 42129500 [PubMed - as supplied by publisher]


The impact of tissue detection on diagnostic artificial intelligence algorithms in prostate digital pathology.
Sci Rep
Boman SE, Mulliqi N, Blilie A, Ji X, Szolnoky K, Gudlaugsson E, Janssen EAM, Kjosavik SR, Asenjo J, Gambacorta M, Libretti P, Braun M, Kordek R, , Hotakainen K, Väre P, Pedersen BG, Sørensen KD, Ulhøi BP, Egevad L, Kartasalo K.
PMID: 42129415 [PubMed - indexed for MEDLINE]


Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities.
Br J Cancer
Waldron NR, Silva D, Westaby D, Jiménez-Vacas J, Taylor J, Sharp A.
PMID: 42129337 [PubMed - as supplied by publisher]


Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study.
Br J Cancer
Yang K, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Jansen L, Brenner H, Arndt V.
PMID: 42129336 [PubMed - as supplied by publisher]


Imaging-based clinical decision tree enables risk stratification of extraprostatic extension before radical prostatectomy in prostate cancer patients.
Insights Imaging
Hamm CA, Rüterhenke T, Baumgärtner GL, Mayerosch C, Schallenberg S, Lindholz M, Beetz NL, Asbach P, Penzkofer T.
PMID: 42129021 [PubMed]


Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.
World J Urol
Cournède M, Gabriel PE, Lottin M, Moschini M, Soria F, D'Andrea D, Shariat SF, Budowski A, Poyet C, Roumiguie M, Alvarez-Maestro M, Briganti A, Krajewski W, Hendricksen K, Veerman H, Afferi L, Mattei A, Di Bona C, Zamboni S, Simeone C, Thenault R, Verhoest G, Gontero P, Xylinas E.
PMID: 42128947 [PubMed - indexed for MEDLINE]


Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials.
Eur Urol Oncol
Tan WS, Kamat AM, Lewis R, Porta N, Ackerman C, Vadiveloo T, Penegar S, Martini A, Vale L, Mostafid H, MacLennan G, Hall E, Heer R, Kelly JD.
PMID: 42128773 [PubMed - as supplied by publisher]


Salivary and serum microRNAs as noninvasive biomarkers for distinguishing prostate cancer from benign prostatic hyperplasia.
Am J Clin Pathol
Salehi M, Alaee M, Mousavi M, Panahi G, Goodarzi D, Amri J.
PMID: 42128534 [PubMed - indexed for MEDLINE]


First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer.
J Immunother Cancer
Xiang JC, Xia ZY, Sun JX, Ye GC, Wang Y, Yang J, Wang SG, Xia QD.
PMID: 42128518 [PubMed - indexed for MEDLINE]


Paraganglioma of the urinary bladder with a novel variant of SDHB mutation.
BMJ Case Rep
Shivani ZA, Puthalath RT.
PMID: 42128441 [PubMed - indexed for MEDLINE]


Nectin4-targeted molecular imaging for precise endoscopic diagnosis and image-guided surgery in bladder cancer.
Cell Rep Med
He Y, Guo H, Wang B, Gao W, Deng Y, Zhao Y, He K, Liang X, Tian J, Wang J, Li X, Du Y.
PMID: 42127904 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 178233    Page 1 of 8912  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1